ALORA LITTLE: Open Payments
NPI 1669253324 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 44 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,062 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $267 |
| Janssen Pharmaceuticals, Inc | 7 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| ABBVIE INC. | 2 | $40 |
| Corium, LLC | 3 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Tris Pharma Inc | 1 | $20 |
Products named: Auvelity, SPRAVATO, CAPLYTA, TRINTELLIX, REXULTI, COBENFY, VRAYLAR, Azstarys.
Industry payments across MS — which companies pay providers there.
